Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

75.35
-1.9700-2.55%
Post-market: 75.350.00000.00%19:39 EDT
Volume:379.16K
Turnover:28.69M
Market Cap:1.73B
PE:16.60
High:77.81
Open:77.33
Low:74.81
Close:77.32
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.41
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.90
PE(LYR):22.70

Loading ...

ANI SVP Thomas Rowland disposes 459 shares for $36,357.39

Reuters
·
May 14

ANI Pharma General Counsel Meredith Cook sells 500 shares worth $39,080

Reuters
·
May 14

ANI Pharma releases corporate presentation outlining rare-disease shift, 2026 revenue outlook $1.1-$1.14 billion

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Definitive Healthcare Corp (DH) and Denali Therapeutics (DNLI)

TIPRANKS
·
May 11

Guggenheim Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

ANI Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $105 From $111

THOMSON REUTERS
·
May 11

ANI Pharmaceuticals (ANIP) Profit Swing And One Off Gain Test Bullish Narratives

Simply Wall St.
·
May 09

H.C. Wainwright Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 09

ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Sector Update: Healthcare Stocks Steady Pre-Bell Friday

MT Newswires Live
·
May 08

Update: ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook

MT Newswires Live
·
May 08

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.19 to $9.69, vs. FactSet Est of $9.07

MT Newswires Live
·
May 08

Stock Track | ANI Pharmaceuticals Soars 5.35% in Pre-market on Strong Earnings Beat, Raised Guidance and $100M Buyback

Stock Track
·
May 08

ANI Pharma Q1 FY26 net income rises 93.1% to USD 29.5 million; revenue increases 20.5% to USD 237.5 million

Reuters
·
May 08

BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3

Reuters
·
May 08

ANI Pharmaceuticals Q1 EPS USD 1.28

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Q1 Adjusted Ebitda USD 63 Million

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Inc: $100 Mln Share Repurchase Program Authorized by Board of Directors

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

THOMSON REUTERS
·
May 08